JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Scope & Guideline

Empowering Researchers with Open Access Knowledge

Introduction

Welcome to your portal for understanding JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1582-1838
PublisherWILEY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2000 to 2024
AbbreviationJ CELL MOL MED / J. Cell. Mol. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The Journal of Cellular and Molecular Medicine focuses on the intersection of cellular and molecular biology, providing insights into the mechanisms underlying disease processes and therapeutic interventions. Its broad scope allows for the exploration of various biological systems, emphasizing the importance of cellular interactions and molecular pathways in health and disease.
  1. Cellular and Molecular Mechanisms of Disease:
    The journal emphasizes research that elucidates the cellular and molecular mechanisms that contribute to various diseases, including cancer, cardiovascular diseases, and metabolic disorders.
  2. Therapeutic Strategies and Drug Development:
    It publishes studies related to novel therapeutic strategies, including drug design, repurposing, and the development of biologics targeting specific cellular pathways.
  3. Translational Research:
    The journal bridges basic research with clinical applications, focusing on findings that have the potential to influence clinical practices and improve patient outcomes.
  4. Innovative Methodologies:
    The journal encourages the use of cutting-edge methodologies, including high-throughput sequencing, single-cell analysis, and advanced imaging techniques, to explore cellular and molecular phenomena.
  5. Interdisciplinary Approaches:
    Research that integrates biology with bioinformatics, systems biology, and computational modeling is highlighted, reflecting the journal's commitment to a multidisciplinary approach in understanding complex biological questions.
The Journal of Cellular and Molecular Medicine has seen a rise in interest in several emerging research areas, reflecting current scientific trends and the evolving landscape of biomedical research.
  1. Ferroptosis and Cell Death Mechanisms:
    Research on ferroptosis, a form of regulated cell death distinct from apoptosis and necrosis, is gaining traction, highlighting its implications in cancer, neurodegeneration, and organ injury.
  2. Exosome Research and Extracellular Vesicles:
    The study of exosomes and their role in intercellular communication, immune responses, and disease progression is emerging as a significant trend, with potential therapeutic applications.
  3. Microbiome and Gut-Brain Axis Studies:
    There is an increasing focus on the interactions between the gut microbiome and various health conditions, including neurological diseases, reflecting a broader interest in holistic approaches to health.
  4. Immunotherapy and Cancer Vaccines:
    Research related to immunotherapy, particularly novel vaccine strategies and immune checkpoint inhibitors, is becoming more prominent, underscoring the shift towards harnessing the immune system in cancer treatment.
  5. Machine Learning and AI in Biomedical Research:
    The integration of machine learning and artificial intelligence in analyzing complex biological data sets is on the rise, indicating a trend toward data-driven approaches in cellular and molecular medicine.

Declining or Waning

While the Journal of Cellular and Molecular Medicine continues to thrive in many areas, certain themes have exhibited a decline in prominence over recent years. This waning interest may reflect shifting research priorities or advancements in other emerging fields.
  1. Traditional Pharmacology:
    There has been a noticeable decrease in studies focusing solely on traditional pharmacological approaches, with a shift towards more innovative and personalized medicine strategies.
  2. Basic Cell Biology:
    Papers centered on fundamental cell biology without direct clinical implications appear to be less frequent, as the journal increasingly prioritizes translational research.
  3. In Vivo Animal Studies:
    Research involving extensive in vivo animal studies is becoming less common, as there is a growing emphasis on human-relevant models and in vitro studies that provide more immediate insights into clinical applications.
  4. Single-Pathway Studies:
    Studies focusing on isolated pathways without considering the broader biological context are declining, as the journal favors comprehensive analyses that consider network interactions and multi-target approaches.

Similar Journals

CELL PROLIFERATION

Fostering Discoveries that Transform Biotechnology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Innovating Research on the Molecular Basis of Disease
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

Function

Empowering global collaboration in cell biology and physiology.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 6 issues/year

Function is a pioneering open access academic journal published by Oxford University Press, dedicated to advancing research in the fields of Cancer Research, Cell Biology, Molecular Medicine, and Physiology. Since its inception in 2020, this journal has quickly established itself as a vital resource for researchers and professionals alike, achieving a commendable impact factor in the 2023 rankings, where it stands in the Q2 quartile across multiple categories. Located in the heart of the United Kingdom, Function aims to foster a global exchange of knowledge by providing free and unrestricted access to cutting-edge research, facilitating collaboration and innovation within the scientific community. With a robust focus on emerging discoveries and interdisciplinary approaches, this journal encourages contributions that unravel the complexities of biological functions, paving the way for transformative advancements in healthcare and related sciences. As it converges from 2020 to 2024, Function continues to be an invaluable platform for disseminating research that has the potential to shape the future of medicine and biology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Bridging Gaps in Cellular Research for a Global Audience
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

CELL BIOLOGY AND TOXICOLOGY

Connecting Cell Biology with Toxicological Insights
Publisher: SPRINGERISSN: 0742-2091Frequency: 6 issues/year

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

Cell Adhesion & Migration

Advancing Knowledge in Cell Biology and Neuroscience
Publisher: TAYLOR & FRANCIS INCISSN: 1933-6918Frequency: 1 issue/year

Cell Adhesion & Migration, published by Taylor & Francis Inc, is a premier open access journal that has been providing a platform for the dissemination of high-quality research since its inception in 2007. With an emphasis on the critical roles that cell adhesion and migration play in various biological processes, this journal endeavors to publish cutting-edge studies in cell biology and cellular and molecular neuroscience. The journal's strong impact is reflected in its classification in the Q2 quartile for both Cell Biology and Cellular and Molecular Neuroscience categories as of 2023, underscoring its significance in advancing knowledge within the scientific community. The journal is accessible globally due to its open access model established in 2019, making it a valuable resource for researchers, professionals, and students aiming to explore innovative findings in cell dynamics and their implications in health and disease. With a commitment to fostering collaboration and dialogue among scientists, Cell Adhesion & Migration continues to be an essential resource in the rapidly evolving fields of cell biology and neuroscience.

FASEB BioAdvances

Pioneering Discoveries in Physiology and Genetics
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Protein & Cell

Unveiling Innovations in Drug Discovery and Biotechnology
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

Autophagy

Elevating Research in the Science of Autophagy
Publisher: TAYLOR & FRANCIS INCISSN: 1554-8627Frequency: 12 issues/year

Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

MOLECULES AND CELLS

Fostering Innovation in Biomedical Research
Publisher: KOREAN SOC MOLECULAR & CELLULAR BIOLOGYISSN: 1016-8478Frequency: 12 issues/year

MOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.